Skip to main content
Mehmet Bilen, MD, Oncology, Atlanta, GA

MehmetAsimBilenMD

Oncology Atlanta, GA

Genitourinary Oncology

Director of Genitourinary Medical Oncology, Winship Cancer Institute of Emory University

Dr. Bilen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bilen's full profile

Already have an account?

  • Office

    Winship Cancer Institute Of Emory University
    Atlanta, GA 30322
    Phone+1 404-778-3460

Summary

  • I serve as Assistant Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. I joined the clinical staff at Winship Cancer Institute as a practicing physician in July 2016. I am actively involved in clinical research and patient care in the area of genitourinary cancers, and serve as the Associate Medical Director of the Phase I Unit at Winship Cancer Institute. I work closely with the Fellowship Program of the Department of Hematology and Medical Oncology by educating fellows on genitourinary oncology. I also serve on the Winship Clinical and Translational Review Committee and Grady Clinical Research Committee.
    I hold professional memberships with American Association for Cancer Research and American Society of Clinical Oncology.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2010 - 2013
  • Hacettepe University FOM
    Hacettepe University FOMClass of 2008

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2016 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Addition of Chemotherapy in the Definitive Management of High Risk Prostate Cancer  
    Bradley C Carthon, Mehmet A Bilen, Omer Kucuk, Urologic Oncology

Authored Content

  • Cabozantinib for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Retrospective AnalysisNovember 2018
  • The Addition of Chemotherapy in the Definitive Management of High Risk Prostate CancerOctober 2018

Press Mentions

  • Immune Cell Find Boosts Cancer Immunotherapy Hopes
    Immune Cell Find Boosts Cancer Immunotherapy HopesOctober 26th, 2024
  • Immune Cell Discovery Offers New Potential for Cancer Immunotherapy
    Immune Cell Discovery Offers New Potential for Cancer ImmunotherapyOctober 25th, 2024
  • Cancer Clinical Trials Are a Win for Patients, Doctors & Researchers
    Cancer Clinical Trials Are a Win for Patients, Doctors & ResearchersJuly 5th, 2022
  • Join now to see all

Grant Support

  • Osteocrines in Therapy Resistance of Prostate Cancer Bone Metastasis: Evaluation of Strategies to Overcome Therapy Resistance from Tumor-Educated Bone Environment.Special Challenge Award - Prostate Cancer Foundation-JanssenPresent

Committees

  • Member, Grady Clinical Research Committee.
  • Member, Winship Clinical and Translational Review Committee

Professional Memberships

Other Languages

  • Turkish